What does combination chemotherapy aim to reduce?

What does combination chemotherapy aim to reduce?

• A. Overall survival rates
• B. Resistance to treatment
• C. Symptomatic treatment options
• D. Side effects of drugs

Answer: (B)

Combination chemotherapy aims to reduce resistance to treatment. This approach involves administering two or more chemotherapy agents that have different mechanisms of action. By using multiple agents, the likelihood of cancer cells developing resistance to the treatment is decreased. This strategy targets various pathways in the cancer cell growth cycle, making it more challenging for the cells to survive and adapt. Using combination therapy can also lead to enhanced efficacy, as the different drugs can work synergistically to attack the cancer more effectively. Over time, cancer cells can develop mechanisms to evade the effects of single-agent therapies, potentially leading to treatment failure. By incorporating a variety of drugs in combination, the likelihood of resistance development is significantly lowered, which is a primary goal of this treatment strategy. This focus on reducing resistance is also essential for improving overall treatment outcomes and increasing the chances of durable responses in patients facing malignancies.

Combination chemotherapy aims to reduce resistance to treatment. This approach involves administering two or more chemotherapy agents that have different mechanisms of action. By using multiple agents, the likelihood of cancer cells developing resistance to the treatment is decreased. This strategy targets various pathways in the cancer cell growth cycle, making it more challenging for the cells to survive and adapt.

Using combination therapy can also lead to enhanced efficacy, as the different drugs can work synergistically to attack the cancer more effectively. Over time, cancer cells can develop mechanisms to evade the effects of single-agent therapies, potentially leading to treatment failure. By incorporating a variety of drugs in combination, the likelihood of resistance development is significantly lowered, which is a primary goal of this treatment strategy.

This focus on reducing resistance is also essential for improving overall treatment outcomes and increasing the chances of durable responses in patients facing malignancies.